Author: Voulgari Paraskevi V
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.13, Iss.1, 2008-03, pp. : 175-196
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging therapies for rheumatoid arthritis
By Jacques Peggy Van den Bosch Filip
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. :
Emerging drugs to treat juvenile idiopathic arthritis
By Ruperto Nicolino Martini Alberto
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. :
Newer drugs for rheumatoid arthritis worth their cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. :